Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva and OncoGenex announce top-line survival results of Phase III SYNERGY trial evaluating custirsen in combination with first-line docetaxel and prednisone - Drug Target Review
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva Reports First Quarter 2021 Financial Results | Business Wire
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet
Infographic: Teva Pharmaceuticals (TEVA) Q1 2020 earnings results | AlphaStreet
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Why Teva Pharmaceutical Is Substantially More (NYSE:TEVA) | Seeking Alpha
DEF 14A
Can Teva Pharmaceutical's Q4 results bring positive surprise? | Seeking Alpha
Teva Pharma shares up after positive results from migraine drug trial: Tirrell
Analysts see upside in Teva share price - גלובס
Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia - Pharmaceutical Business review
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
Teva Pharmaceuticals: Making Quality Health Care Accessible
Why Teva Pharmaceuticals Stock Has Two A-Products In The Bag (NYSE:TEVA) | Seeking Alpha
